Detalles de la búsqueda
1.
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(6): 504-513, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379158
2.
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.
BMC Cancer
; 22(1): 732, 2022 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790916
3.
Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells.
Int J Mol Sci
; 23(17)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077379
4.
The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study.
BMC Cancer
; 21(1): 1048, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34556072
5.
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.
BMC Cancer
; 21(1): 977, 2021 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34465283
6.
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.
BMC Cancer
; 21(1): 230, 2021 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676426
7.
An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors.
Carcinogenesis
; 40(1): 27-40, 2019 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30428017
8.
Hyperprogression after first dose of immunotherapy in a patient with radioresistant metastasis from nonsmall cell lung cancer.
Anticancer Drugs
; 30(10): 1067-1070, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31567311
9.
Intestinal Permeability Study of Clinically Relevant Formulations of Silibinin in Caco-2 Cell Monolayers.
Int J Mol Sci
; 20(7)2019 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-30935093
10.
Probable drug-drug interaction between erlotinib and amiodarone causes severe neurotoxicity in a patient with advanced lung cancer.
Anticancer Drugs
; 29(4): 380-383, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29420339
11.
Ethics competences in the undergraduate medical education curriculum: the Spanish experience.
Croat Med J
; 57(5): 493-503, 2016 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27815940
12.
Silibinin is a suppressor of the metastasis-promoting transcription factor ID3.
Phytomedicine
; 128: 155493, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38484626
13.
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.
Clin Lung Cancer
; 25(3): 274-279, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310035
14.
Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry.
Lung Cancer
; 190: 107513, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38432027
15.
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
Arch Bronconeumol
; 60(2): 88-94, 2024 Feb.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-38160163
16.
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(3): 233-243.e8, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105153
17.
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP.
Clin Transl Oncol
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38530556
18.
Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.
J Transl Med
; 11: 13, 2013 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23311395
19.
Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.
JCO Clin Cancer Inform
; 7: e2200062, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37428988
20.
Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.
Transl Lung Cancer Res
; 12(10): 2113-2128, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025806